In Setback for Glaxo, U.K. Invalidates Paxil Patent
The U.K. House of Lords has upheld a lower court's decision to invalidate the patent for the key ingredient in GlaxoSmithKline's Paxil, one of the world's most widely prescribed antidepressants....To view the full article, register now.
Already a subscriber? Click here to view full article